Announcements Citizenship, Governance and Accountability in Health – Join the COPASAH Conclave of Global Health Accountability and Human Rights Advocates: October 15-18, 2019 New Delhi, India   |   Open Letter: Stop the war on Syria’s hospitals
Dublin Core PKP Metadata Items Metadata for this Document
1. Title Title of document Financial incentives and the prescription of newer vaccines by doctors in India
2. Creator Author's name, affiliation, country Rakesh Lodha; All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India
3. Subject Discipline(s)
3. Subject Keyword(s)
4. Description Abstract The pharmaceutical industry spends a significant amount of resources on marketing its products. According to one estimate, the top 50 companies in India alone spent Rs 5,340 crore in 2004 on drug promotion, spending 290% to 1,025% more on marketing than on research and development. The interactions between the pharmaceutical industry and the medical profession related to promotion of medicines have been described as an entanglement; 16 forms of this entanglement have been described, and they range from acceptance of gifts and sponsorship of lavishly organised continuing medical education events featuring industry-sponsored speakers, to industry-sponsored research. While physicians claim that they are not influenced by the promotional practices of the industry, there is compelling evidence that aggressive promotional efforts lead to irrational and incautious use of more expensive, newer medicines, and escalation of healthcare costs. The primary responsibility of physicians is to promote their patients` best interests, while the primary concern of the industry is to promote profitability. In the past few years, there has been increasing concern over the influence of the pharmaceutical industry over the practice of medicine, medical education and research, and guidelines of professional bodies strongly discourage physicians from accepting costly gifts, hospitality, trips and subsidies of any type from the industry. The WHO`s criteria for ethical medicinal promotion clearly prohibit industry from offering financial inducement and incentives. In India, where unethical drug promotion is a significant problem, the Medical Council of India`s code of conduct still does not address what constitutes appropriate, ethical and legal conduct in the interactions between professionals and their associations with the pharmaceutical industry.
5. Publisher Organizing agency, location Forum for Medical Ethics Society
6. Contributor Sponsor(s)
7. Date (YYYY-MM-DD) 2016-11-30
8. Type Status & genre
8. Type Type
9. Format File format HTML , PDF
10. Identifier Uniform Resource Identifier
11. Source Title; vol., no. (year) Indian Journal of Medical Ethics;: Debates
12. Language English=en en
13. Relation Supp. Files
14. Coverage Geo-spatial location, chronological period, research sample (gender, age, etc.)
15. Rights Copyright and permissions

All articles published in IJME are available on its website free of charge. The copyright for published material belongs to IJME/FMES. IJME freely permits the reprint (or reproduction on a website) of articles from the journal, as long as this is for non-commercial use and appropriate credit is given to the author and the journal and publication details are mentioned. The commercial use of our content can be made only after obtaining permission from and on payment to IJME. This is intended to support production of the journal.